Cite

HARVARD Citation

    Yang, C. et al. (2020). Intrathecal administration of SRT1720 relieves bone cancer pain by inhibiting the CREB/CRTC1 signalling pathway. Neuroscience letters. p. . [Online]. 
  
Back to record